An extract from my research report published this morning: Moderna Inc is a name I added on 25 May at $169.47 (see attached), well ahead of the price surge to nearly $500. It's retraced sharply, to the rising trend line, with a close of 231.19 by Friday. It’s a higher risk play but the level could provide an entry for a moderate rebound as Covid-19 cases resurface globally.
Pre-market: $234.65 with a stop of $225.00.
Note: it could print a lower price intraday but like it around these levels.
Manage your risk.
Also seen: Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery.
Pre-market: $234.65 with a stop of $225.00.
Note: it could print a lower price intraday but like it around these levels.
Manage your risk.
Also seen: Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery.
